Oncology & Cancer

Older lung cancer patients face significant treatment burden

Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according ...

Oncology & Cancer

Support for first-line erlotinib in NSCLC with EGFR mutations

(HealthDay)—For patients with non-small-cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations, erlotinib is active, and treatment beyond progression is feasible and may delay salvage ...

Oncology & Cancer

Doctors often overtreat with radiation in late-stage lung cancer

Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.

page 13 from 24